Cancer-Related Dictionary

Monoclonal antibodies are laboratory-made proteins that mimic the immune system's ability to fight off harmful pathogens such as viruses. They are specially engineered to target a specific disease-causing agent, enhancing the body's natural responses against the disease. They are used in various therapies including cancer and autoimmune diseases treatments.

Monoclonal gammopathy of undetermined significance (MGUS) is a medical condition where abnormal proteins, called monoclonal proteins or M proteins, are present in the blood. It's typically harmless, but may occasionally lead to serious disorders like blood cancers. MGUS lacks distinct symptoms and is often detected during routine blood tests.

Myelodysplastic syndromes (MDS) refer to a group of diverse bone marrow disorders where the body does not produce sufficient healthy blood cells. As a result, patients with MDS often exhibit anemia, fatigue, frequent infections, and easy bruising or bleeding. It's generally diagnosed in the elderly and could progress into acute myeloid leukemia.

Neoplasm is a medical term referring to an abnormal growth of tissue which can be benign (not cancerous), malignant (cancerous), or precancerous. It arises due to unprecedented and uncontrolled cell division. The nature of the neoplasm can be determined by biopsy or other diagnostic techniques.

Neuro-oncology is a specialized branch of medicine that focuses on the study, diagnosis, and treatment of tumors affecting the central nervous system (CNS), which includes the brain and spinal cord. Practitioners in neuro-oncology, known as neuro-oncologists, are medical professionals who specialize in understanding and managing tumors of the nervous system. This field involves collaboration between neurologists, neurosurgeons, oncologists, and other healthcare professionals to provide comprehensive care for individuals with brain and spinal cord tumors. The goal of neuro-oncology is to improve the understanding of the underlying mechanisms of these tumors, enhance diagnostic methods, and develop effective treatment strategies to improve outcomes for patients with neuro-oncological conditions.

A neutrophil is a type of white blood cell, which is the most abundant in the human body. They are essential components of the immune system, acting as the body's first line of defense against infections by engulfing and destroying harmful bacteria and fungi. Neutrophils play a vital role in maintaining overall health and fighting diseases.

Oncogenes are genes that can potentially cause cancer. When they are normal, they help to regulate cell growth and division. However, when they are altered or mutated, they can lead to abnormal cell growth and proliferation, eventually fostering the development of cancer.

An oncogenic virus is a type of virus that can cause cancer by altering the genetic material of the host cells it infects. These viruses can disrupt normal cell regulation and lead to uncontrolled cell growth.

An oncologist is a specialized medical doctor who diagnoses and treats cancers. This expert is involved in the patient's care from diagnosis to treatment, utilizing therapies like chemotherapy, radiation, and surgeries to manage the disease. Oncologists often collaborate with a team of healthcare professionals to provide personalized care for each patient.

Oncology is a branch of medicine that specializes in the diagnosis, treatment, and prevention of various types of cancer. It includes medical professionals known as oncologists who use various therapies like chemotherapy, radiation, and surgery to combat cancerous cells.

An oncovirus is a type of virus that can cause cancer. This happens when the viruses alter the cell regulatory genes, leading to uncontrolled cell growth and division, which eventually forms a malignant tumor. Oncoviruses are responsible for approximately 12% of all human cancers.

A partial response refers to a situation where a patient experiences a regression of a disease or its symptoms but not to the extent of a complete eradication. It is commonly used in healthcare, particularly in cancer treatment, where it indicates a significant decrease in tumor size or disease markers but not their total disappearance.

A pathologist is a medical professional specializing in studying diseases and their causes, effects, and processes. They perform laboratory tests on patient samples, interpret the results to aid in diagnosis, and consult with other physicians to ensure appropriate treatment plans. Their expertise is vital in detecting serious conditions like cancer and infections. They also contribute to health maintenance by evaluating screening tests.

Pediatric oncology is a medical specialty focused on the diagnosis and treatment of cancers occurring in children and adolescents. This branch combines various treatments like chemotherapy, radiation therapy, surgery and stem cell transplantation, along with research on cancer biology and genetics. The aim is to effectively treat and ideally achieve remission, while reducing potential side effects and improving the quality of life for young patients.

Perineural invasion refers to a pathological process where cancer cells invade the spaces surrounding nerves. Typically detected under a microscope during tissue exams, this process often indicates aggressive cancer and can lead to increased risk of recurrence post-treatment. It's commonly observed in various cancers like prostate, head & neck, colorectal, among others.

A placebo is a harmless, inactive substance or treatment given to a patient, often used in clinical trials as a control group. It's designed to resemble actual medication in appearance and administration, without therapeutic effects. Its aim is to measure the impact of belief on health outcomes and to isolate the efficacy of the actual treatment under consideration.

Plasmacytoma refers to a malignant tumor formed by abnormal plasma cells, which are a type of white blood cells responsible for producing antibodies. These tumors often occur in the bone marrow and soft tissues. Although they are generally observed as isolated lesions, their occurrence could be an early sign of multiple myeloma, a cancer of plasma cells.

A "platelet count" is a lab test that measures the number of platelets, which are small blood cells that help in blood clotting, in a person's blood. It is used to diagnose diseases and monitor treatment effectiveness. Low or high platelet counts can indicate a medical condition that requires treatment.

Platelets, also known as thrombocytes, are small, colorless cell fragments in our blood that form clots and stop or prevent bleeding. These essential components of the blood are produced in the bone marrow and serve a crucial role in blood coagulation, wound healing, and inflammation response.###

A polyp is a small, abnormal growth of tissue that develops on the lining of a body part, such as the cervix, colon, or nasal passage. Typically benign (non-cancerous), polyps can sometimes become malignant (cancerous). Their size, number, and location can influence the treatment approach.

"Precancerous" refers to cells that have abnormal changes and might transform into cancer over time, but are not yet cancerous themselves. This term is often used to describe conditions that significantly increase the risk of cancer, such as certain types of skin lesions or polyps in the colon. However, not all precancerous conditions will necessarily develop into cancer.

"Preclinical" refers to the phase of research conducted before a new drug or treatment is tested on humans. This stage involves laboratory experiments using cell cultures and animal testing to determine the efficacy, potential side effects, and optimal dosage. It is a fundamental step in drug development and policy-making in healthcare.

A primary tumor is the original growth of cancer cells that initially forms in the body. It is typically the first indication or onset of cancer within a specific organ or tissue. The primary tumor can metastasize, spreading to different body parts, resulting in secondary tumors. Treatments often target the primary tumor first to stop further spread of cancer.

Prognosis refers to the likely course or outcome of a disease, condition, or patient's recovery based on the general outlook of the identified condition. It provides estimates about chances of recovery, disease progression, and survival rates based on factors such as patient's health, type of disease and treatment.

Prognostic factors are specific characteristics that help predict the likely outcome or course of a disease in a patient. These factors can include age, stage of disease, and specific biological markers, and they assist healthcare providers in determining the best treatment approach.

Progression-Free Survival (PFS) is a medical term used in oncology to denote the length of time during and after treatment, a patient lives with a disease that does not worsen. It's an essential measure in assessing the efficacy of new cancer treatment drugs or methodologies.

Prolactin is a hormone produced by the pituitary gland, primarily responsible for stimulating milk production after childbirth. Also, it plays a role in fertility by inhibiting follicle-stimulating hormone (FSH) and gonadotropin-releasing hormone (GnRH). Elevated levels can cause reproductive problems in both men and women.

Protein biomarkers are specific proteins found in the body that can be measured and used to indicate a biological state, such as the presence of a disease or condition. They help in diagnosing diseases, predicting disease progression, and monitoring treatment responses.

Quality of Life (QoL) refers to the overall well-being of an individual, encompassing both physical and mental states, including health, happiness, job satisfaction, family life, education, and safety. It is a broad concept impacted by various individual life factors, often used to evaluate the general well-being in different societies and cultures.

A Radiation Oncologist is a medical professional specialized in the use of radiation therapy to treat various types of cancer. They plan and administer the right dosage of radiation to accurately target the cancerous cells while minimizing damage to surrounding healthy tissues. They collaborate with other physicians in a multidisciplinary team to provide holistic cancer care.

"Receptor status" refers to the presence or absence of particular proteins (receptors) on the surface of cancer cells. These receptors influence how the cancer behaves and responds to treatment. They are typically identified in laboratory tests, helping doctors guide the most effective treatment. Common examples include hormone receptors in breast cancer and human epidermal growth factor receptor-2 in certain types of cancers.

Recurrence refers to the act of occurring again or repeating. In a health context, it often refers to the return of a disease or condition after a period of improvement or apparent cure. It can also apply to repeated patterns or events in various other disciplines, such as mathematics, engineering, or computer science.

Regulatory science is a science that develops the (technical) foundations, processes, methods, and tools to formulate regulatory requirements that ensure the safety, performance, and efficacy of pharmaceuticals and medical devices. It encompasses basic and applied biomedical and social sciences and contributes to the development of regulatory standards and tools.

Remission refers to the state where the signs and symptoms of a disease or condition temporarily or completely disappear. It's often used in context to chronic or severe diseases like cancer, indicating a period where the disease is under control or undetectable. However, remission doesn't necessarily mean a cure, as the disease can return.

Renal angiomyolipoma is a benign tumor of the kidney composed of blood vessels, muscle, and fat. It is usually non-cancerous and often goes undetected unless it causes symptoms or complications.

Residual disease refers to the small amount of cancer cells that may remain in the body after treatment, which can lead to a recurrence if not effectively managed.

Risk stratification is a process used in healthcare to categorize patients based on their risk of developing certain diseases or complications. It helps doctors prioritize care and tailor treatments based on the level of risk.

Squamous metaplasia is a process where one type of mature cell is replaced by another type of mature cell. This usually occurs as an adaptation to chronic irritation or inflammation, where glandular cells transform into squamous cells, which are more resistant to such conditions.

"Staging" in the healthcare context, refers to the process of determining the size and spread of a specific disease or cancer within the patient's body. It facilitates the development of an appropriate treatment plan, and helps predict patient prognosis. The stage is often denoted by Roman numerals I, II, III, or IV.

A surgical oncologist is a specialist in the field of oncology, responsible for the surgical removal of tumors and cancerous tissues. They work as part of a multidisciplinary team, providing surgical interventions, performing biopsies, and contributing to treatment planning for cancer patients. Their expertise lies in cancer surgery and understanding tumor biology.

A T-cell, also known as a T-lymphocyte, is a type of white blood cell that plays a fundamental role in the immune system. T-cells primarily perform the role of identifying and destroying abnormal or infected cells, including bacteria and viruses, to protect the body from infection or disease. They also aid in stimulating other immune responses. The 'T' stands for thymus, the gland in which these cells mature.

"Transition" refers to the process or period of changing from one state, condition, or place to another. It can relate to personal developments, such as life transitions, or wider societal changes. It can also pertain to the movement in writing or speech from one point or topic to another, ensuring logical coherence and flow.

A tumor refers to a mass or lump of abnormal cells in the body which can be benign (non-cancerous), pre-malignant (pre-cancerous), or malignant (cancerous). Tumors can occur anywhere in the body and may grow slowly or rapidly. They may cause symptoms due to their size or location, or can be asymptomatic. Tumors are generally diagnosed through imaging tests, biopsies, and other medical examinations.

Tumor burden refers to the total amount of cancer present in a person's body. It includes the size of the tumor, the number of cancerous cells, and the extent to which cancer has spread to other parts of the body.

Tumor progression refers to the process by which a tumor grows and potentially becomes more aggressive, spreading to other parts of the body. This involves changes at the cellular level, where cancer cells divide uncontrollably, invade nearby tissues, and may metastasize to distant organs.

Tumor markers are substances, often proteins, found in blood, urine, and tissue, produced by cancerous cells or by the body in response to cancer. They are valuable as they can indicate the presence, type, and progression of a malignancy. However, these markers are not entirely specific to cancer and can be elevated in non-cancerous conditions.

Vascular endothelial growth factor (VEGF) is a protein that stimulates the growth of blood vessels. More specifically, it promotes angiogenesis (the formation of new blood vessels from pre-existing ones), vascular permeability, and endothelial cell growth. It plays a significant role in various biological processes, such as embryonic development and wound healing, but is also implicated in diseases like cancer.

Viral oncogenesis refers to the process by which viruses can cause cancer in humans and animals. Certain viruses can alter the genetic material of cells, leading to uncontrolled cell growth and the development of tumors.

White blood cells, also known as leukocytes, are crucial components of the immune system that defend the body against both infectious diseases and foreign materials. They originate from stem cells in the bone marrow and are partitioned into granulocytes (neutrophils, eosinophils, basophils) and non-granulocytes (lymphocytes, monocytes).

Young adult cancer refers to any type of cancer that is diagnosed in individuals within the young adult age group, typically considered between the ages of 15 and 39. These cancers can have unique biological characteristics and often present specific challenges related to physical and emotional development, reproductive health, and long-term survivorship.